Compounding pharmacies in Delaware

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

The Delaware Board of Pharmacy (Division of Professional Regulation) regulates compounding pharmacies in Delaware. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Delaware at a glance

Pharmacy regulator: Delaware Board of Pharmacy (Division of Professional Regulation)
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Delaware

No verified compounding pharmacies serving Delaware are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Delaware

The Delaware Board of Pharmacy licenses pharmacies under Title 24, chapter 25 of the Delaware Code and its Board regulations. Delaware has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Chapter 25 was reorganized by 85 Del. Laws chapter 49, effective June 30, 2026; in the current Delaware Code, checked 2026-09-22, a pharmacy in another state that delivers, dispenses, or distributes a prescription drug to a Delaware patient must hold a Delaware nonresident pharmacy license (section 2535), which requires good standing in every state where it is licensed and the most recent Board-approved inspection report covering the business it will conduct in Delaware, performed by or for its home-state licensing authority (or, if the home state has not inspected, by a national pharmacy verification program or another qualified entity). It must designate a Delaware registered agent (section 2536), keep a valid home-state license, and may be disciplined for failing to send the Board later inspection reports within 60 days of receiving them (section 2537). The Board's regulations (24 Del. Admin. Code 2500) require all compounding to comply with section 503A of the federal act (regulation 5.1.6) and require every Board licensee that compounds to comply with USP chapters 795 and 797 (regulation 10.0). [1] [4] [5] [6] [8]

Compounded GLP-1 access in Delaware

Delaware patients using an out-of-state telehealth GLP-1 program should confirm the prescriber is Delaware-licensed or holds an interstate telehealth registration, and that the pharmacy holds a Delaware nonresident pharmacy license. [3] [5] [11]

Research use only sellers in Delaware

Only Delaware-licensed pharmacies and licensed nonresident pharmacies may dispense prescription drugs to Delaware patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law, are not dispensed by a pharmacist, and fall outside Delaware's pharmacy licensing system. Delaware's own food and drug law (16 Del. C. chapter 33, Pure Food and Drugs) prohibits manufacturing or selling an adulterated or misbranded drug (section 3302) but has no separate new-drug approval provision, so the prohibition on selling unapproved new drugs comes from federal law. [5] [7] [12]

Delaware notes on specific peptides

Semaglutide: Available branded by prescription through telehealth under 24 Del. C. chapter 60, including from out-of-state physicians with a Delaware interstate telehealth registration. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [3] [11]

How to check a compounding pharmacy in Delaware

Search the Delaware Board of Pharmacy (Division of Professional Regulation) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Delaware requires before it ships to you. [1] [4] [5] [6] [8]
Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Delaware. [5] [7] [12]

Common questions in Delaware

What does an out-of-state pharmacy need to ship compounded peptides to Delaware?

A Delaware nonresident pharmacy license. The pharmacy must also designate a Delaware registered agent, keep its home-state license valid, and send the Board of Pharmacy its inspection reports. Check the Division of Professional Regulation license lookup before ordering. [1] [5]

Can a Delaware pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [9] [10]

All peptide legal questions for Delaware